Bernard J. Zovighian

Chief Executive Officer at Edwards Lifesciences

Since May 2023

Age

56 years

Education

Earned dual master’s degrees in science and business from the Universities of Marseille, France.

Tenure

Joined EW in January 2015 as Vice President and General Manager of the Surgical Structural Heart business, later promoted to Corporate Vice President roles, served as President from January 2023 to May 2023, and was appointed CEO in May 2023.

Also at Edwards Lifesciences

AMD

Andrew M. Dahl

Senior Vice President, Principal Accounting Officer

CMS

Catherine M. Szyman

Corporate Vice President, Critical Care

DEBJ

Donald E. Bobo, Jr.

Corporate Vice President, Strategy & Corporate Development

About

Bernard J. Zovighian has built a remarkable career in the medical technology industry, with nearly 30 years of experience driving innovation and patient care. His journey began at EW in January 2015 when he joined as Vice President and General Manager of the Surgical Structural Heart business, a role that laid the foundation for his rapid progression within the company.

Over the years, he was promoted to key leadership positions, including Corporate Vice President for both the Surgical Structural Heart and Transcatheter Mitral and Tricuspid Therapies businesses, and later served as President from January 2023 to May 2023. In May 2023, he was named Chief Executive Officer, further solidifying his instrumental role in EW’s strategic growth and post-pandemic recovery.

Prior to joining EW, he honed his leadership skills during nearly 20 years at a major global healthcare company, where he held increasingly responsible roles including that of Worldwide President. With an educational foundation marked by dual master’s degrees in science and business , his broad expertise and global vision have propelled innovative advancements and reinforced strong operational standards throughout his professional journey.

$EW Performance Under Bernard J. Zovighian

Past Roles

Organization	Role	Date Range	Details
Edwards Lifesciences Corporation	President	January 2023 - May 2023	Preceded appointment as CEO in May 2023
Edwards Lifesciences Corporation	Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies (TMTT)	January 2018 - January 2023	Led development of a portfolio of therapies
Edwards Lifesciences Corporation	Corporate Vice President / Vice President, Surgical Structural Heart	2015 - January 2018	Managed the Surgical Structural Heart business
Edwards Lifesciences Corporation	Vice President and General Manager, Surgical Structural Heart business	2015	Joined the company
Johnson & Johnson	Worldwide President (Division)	N/A	Held this role for nearly 20 years
Johnson & Johnson	Regional Operations Leader	N/A	Held leadership roles in regional operations outside the U.S.
Johnson & Johnson	Worldwide President, Sterilization & Infection Prevention Division	N/A	Held this role during his tenure

External Roles

Organization	Role	Date Range	Details
University of Southern California	Advisory Board Member	N/A	Leonard D. Schaeffer Center for Health Policy & Economics

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Salary	$972,814	Annual (2023)	Includes $153,469 deferred into EDCP
Registrant Contributions to EDCP	$38,670	Annual (2023)	Company contributions to EDCP
Medical and Dental Coverage Continuation	$59,659	Payment upon termination in connection with a change in control	Coverage continuation benefit

Performance Compensation

Data from FY 2023

No information available on performance compensation for 2023